CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a new pneumococcal vaccine that provides broad protection against various strains of the bacteria. The vaccine, PnuBioVax™, is designed to be cost-effective, making it accessible for use in developing countries to combat high mortality rates from pneumococcal disease.
Pneumococcal disease, caused by the pathogenic bacteria Streptococcus pneumoniae, is a major cause of mortality in the young and elderly.
In Europe, it is responsible for 230,000 annual deaths and an economic burden of € 10B annually.
Due to the high cost of the current vaccines, rates of infant disease and death are even higher in developing countries, accounting for 1.6M deaths per year.
The introduction of pneumococcal vaccines in Europe over the 20th century was pivotal in the reduction of p…
IMMUNOBIOLOGY LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
